Calliditas Therapeutics AB (Calliditas Therapeutics AB) YoY EPS Growth

: -112.90% (As of Dec. 2023)

View and export this data going back to 2020. Start your Free Trial

YoY EPS Growth is the percentage change of Earnings per Share (Diluted) over the past twelve months. Calliditas Therapeutics AB's YoY EPS Growth for the quarter that ended in Dec. 2023 was -112.90%.

Calliditas Therapeutics AB's Earnings per Share (Diluted) for the three months ended in Dec. 2023 was $-0.07.

Calliditas Therapeutics AB YoY EPS Growth Historical Data

The historical data trend for Calliditas Therapeutics AB's YoY EPS Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Calliditas Therapeutics AB Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

YoY EPS Growth

66.84

-1,135.29

6.28

30.76

-13.01

Calliditas Therapeutics AB Quarterly Data
	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Jun23	Sep23	Dec23
YoY EPS Growth																-163.27	98.70	61.50	21.36	-112.90

Calliditas Therapeutics AB YoY EPS Growth Calculation

YoY EPS Growth is the percentage change of Earnings per Share (Diluted) over the past twelve months.

Calliditas Therapeutics AB's YoY EPS Growth for the fiscal year that ended in Dec. 2023 is calculated as:

	YoY EPS Growth (A: Dec. 2023 )
=	(Earnings per Share (Diluted) (A: Dec. 2023 )	-	Earnings per Share (Diluted) (A: Dec. 2022 ))	/	\| Earnings per Share (Diluted) (A: Dec. 2022 ) \|
=	(-1.694	-	-1.499)	/	\| -1.499 \|
=	-13.01 %

Calliditas Therapeutics AB's YoY EPS Growth for the quarter that ended in Dec. 2023 is calculated as:

	YoY EPS Growth (Q: Dec. 2023 )
=	(Earnings per Share (Diluted) (Q: Dec. 2023 )	-	Earnings per Share (Diluted) (Q: Sep. 2022 ))	/	\| Earnings per Share (Diluted) (Q: Sep. 2022 )) \|
=	(-0.066	-	-0.031)	/	\| -0.031 \|
=	-112.90 %

Calliditas Therapeutics AB YoY EPS Growth Related Terms

Thank you for viewing the detailed overview of Calliditas Therapeutics AB's YoY EPS Growth provided by GuruFocus.com. Please click on the following links to see related term pages.

Calliditas Therapeutics AB (Calliditas Therapeutics AB) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Calliditas Therapeutics AB (NAS:CALT) » Definitions » YoY EPS Growth

Comparable Companies

Traded in Other Exchanges

CALTX:Sweden CALTXs:UK LC8:Germany

Address

Kungsbron 1, D5, Stockholm, SWE, SE-111 22

Website

https://www.calliditas.se

Calliditas Therapeutics AB is a commercial-stage biopharma company focused on identifying, developing, and commercializing novel treatments in orphan indications, with an initial focus on renal and hepatic diseases with unmet medical needs. The company's pipeline candidate is TARPEYO medication to reduce proteinuria in IgA nephropathy.